Her primary scientific interests are in Vaccination, Cervical cancer, Internal medicine, Chronic fatigue syndrome and Gynecology. Elizabeth R. Unger has researched Vaccination in several fields, including Human Papilloma Virus Vaccine, Hpv vaccination, HPV vaccines, Papillomavirus Vaccines and Young adult. Her work deals with themes such as Viral disease, Epidemiology, Immunology and Public health, which intersect with Cervical cancer.
The study incorporates disciplines such as Endocrinology and Physical examination in addition to Chronic fatigue syndrome. Her Gynecology research incorporates elements of Cancer, Alphapapillomavirus, Human papillomavirus, Cytology and Obstetrics. Elizabeth R. Unger studied Genital warts and Cervix that intersect with HPV infection.
Her primary areas of study are Internal medicine, Human papillomavirus, Gynecology, Cervical cancer and Vaccination. The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Oncology. Her work focuses on many connections between Human papillomavirus and other disciplines, such as Virology, that overlap with her field of interest in Molecular biology and In situ hybridization.
Her Gynecology research is multidisciplinary, relying on both Incidence, Young adult, Cytology, Obstetrics and Sexually transmitted disease. Her Cervical cancer research is multidisciplinary, incorporating elements of Epidemiology and Genotype. Her biological study spans a wide range of topics, including Human Papilloma Virus Vaccine, Hpv vaccination, Papillomavirus Vaccines and Confidence interval.
Elizabeth R. Unger focuses on Human papillomavirus, Vaccination, Internal medicine, Confidence interval and HPV infection. The concepts of her Human papillomavirus study are interwoven with issues in Hpv testing, Hpv types, Cytology, Cervical cancer screening and Antibody. Her studies in Vaccination integrate themes in fields like Young adult, Cervical cancer, Cervical intraepithelial neoplasia and Human papillomavirus vaccination.
Elizabeth R. Unger works mostly in the field of Internal medicine, limiting it down to topics relating to Public health and, in certain cases, Colposcopy, as a part of the same area of interest. Her Confidence interval study combines topics from a wide range of disciplines, such as Human Papilloma Virus Vaccine, Men who have sex with men and National Health and Nutrition Examination Survey. She interconnects Odds ratio and Incidence in the investigation of issues within HPV infection.
Her primary scientific interests are in Vaccination, Human papillomavirus, Confidence interval, Cervical intraepithelial neoplasia and Cervical cancer. Her study in Vaccination is interdisciplinary in nature, drawing from both Human papillomavirus vaccination, Antibody, HPV infection and Papillomavirus Vaccines. Her research in HPV infection intersects with topics in Hpv vaccination, Immunization and Family medicine.
Elizabeth R. Unger combines subjects such as Young adult, Human Papilloma Virus Vaccine, National Health and Nutrition Examination Survey and Hpv testing with her study of Confidence interval. Her Cervical intraepithelial neoplasia research integrates issues from Adenocarcinoma in situ, Human papillomavirus vaccine and Obstetrics. Her Cervical cancer study is associated with Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Lauri E Markowitz;Eileen F Dunne;Mona Saraiya;Herschel W Lawson.
Morbidity and Mortality Weekly Report (2007)
Prevalence of HPV Infection Among Females in the United States
Eileen F. Dunne;Elizabeth R. Unger;Maya Sternberg;Geraldine McQuillan.
JAMA (2007)
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.
Emiko Petrosky;Joseph A. Bocchini;Susan Hariri;Harrell Chesson.
Morbidity and Mortality Weekly Report (2015)
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz Le;Dunne Ef;Saraiya M;Chesson Hw.
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control (2014)
Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010
Lauri E. Markowitz;Susan Hariri;Carol Lin;Eileen F. Dunne.
The Journal of Infectious Diseases (2013)
US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
Mona Saraiya;Elizabeth R. Unger;Trevor D. Thompson;Charles F. Lynch.
Journal of the National Cancer Institute (2015)
Prevalence and Incidence of Chronic Fatigue Syndrome in Wichita, Kansas
Michele Reyes;Rosane Nisenbaum;David C. Hoaglin;Elizabeth R. Unger.
JAMA Internal Medicine (2003)
Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution.
William C Reeves;Andrew Lloyd;Suzanne D Vernon;Nancy Klimas.
BMC Health Services Research (2003)
Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006.
Susan Hariri;Elizabeth R. Unger;Maya Sternberg;Eileen F. Dunne.
The Journal of Infectious Diseases (2011)
Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies.
Mangalathu S. Rajeevan;Daya G. Ranamukhaarachchi;Suzanne D. Vernon;Elizabeth R. Unger.
Methods (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
University of Iowa
Yale University
Cedars-Sinai Medical Center
University of Southern California
University of California, San Francisco
Centers for Disease Control and Prevention
Nova Southeastern University
Vanderbilt University Medical Center
National Taiwan University
Malina Software Corp.
University of Birmingham
University of British Columbia
Argonne National Laboratory
University of Montpellier
Macquarie University
Novartis (Switzerland)
Queen's University Belfast
Pennsylvania State University
Johns Hopkins University
University of Bern
University of Tübingen
University of New South Wales
University of Washington
The University of Texas at Austin